author-photo

Roberto Carmagnani Pestana

University of Texas MD Anderson Cancer Center

41

Papers

189

Citations

Citation Trend

Filter By

Papers (28) Sort By

Journal Conference Others

Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Antibody-drug conjugates: Smart chemotherapy delivery across tumor histologies.

2021 CA: A Cancer Journal for Clinicians
Show All
- Source
- Cite
- Save
Citations (0)
Moving Beyond 3+3: The Future of Clinical Trial Design.

2021
Show All
- Source
- Cite
- Save
Citations (1)
Hepatocellular Carcinoma Immunotherapy.

2021 Annual Review of Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib.

2021 Oncotarget
Show All
- Source
- Cite
- Save
Citations (0)
Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implications

2021 Current Problems in Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Histology-agnostic drug development — considering issues beyond the tissue

2020 Nature Reviews Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (23)
Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma

2020 Oral Oncology
Show All
- Source
- Cite
- Save
Citations (13)
Origin and role of hepatic myofibroblasts in hepatocellular carcinoma

2020 Oncotarget
Show All
- Source
- Cite
- Save
Citations (7)
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients.

2020 Oncology
Show All
- Source
- Cite
- Save
Citations (1)